Designs and Analyses of Psychotropic and Behavioral Interventions for the Treatment of Problem Behavior Among People With Intellectual and Developmental Disabilities

被引:11
作者
Courtemanche, Andrea B. [1 ]
Schroeder, Stephen R. [1 ]
Sheldon, Jan B. [1 ]
机构
[1] Univ Kansas, Lawrence, KS 66045 USA
来源
AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES | 2011年 / 116卷 / 04期
关键词
DEFICIT HYPERACTIVITY DISORDER; RANDOMIZED CONTROLLED-TRIALS; FUNCTIONAL-ANALYSIS; MENTAL-RETARDATION; SOCIAL VALIDITY; CLINICAL-TRIALS; ABERRANT BEHAVIOR; DOUBLE-BLIND; MEDICATION; CHILDREN;
D O I
10.1352/1944-7558-116.4.315
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
A combination of behavioral and medication-based interventions has been the most effective form of treatment for reducing problem behavior in individuals with intellectual and developmental disabilities. Evaluating the 2 types of interventions in combination and separately may require that researchers adapt methods traditionally used to evaluate drug interventions for individuals without disabilities. Some methodological difficulties that arise when evaluating drug treatments with this population include the withholding of treatment from control groups, identifying large homogeneous samples of participants, predicting individual clinical responsiveness, and many others. The purpose of this article is to summarize the methodological problems that arise when studying drug behavior interactions among people with intellectual and developmental disabilities and to suggest alternative methods that may ameliorate these issues.
引用
收藏
页码:315 / 328
页数:14
相关论文
共 71 条
[21]  
KAHNG S, 2000, AM J MENT RETARD, V107, P212
[22]  
KLERMAN GL, 1975, DRUGS COMBINATION OT, P67
[23]  
LIPMAN RS, 1970, PSYCHIAT APPROACHES
[24]   AACAP 2002 Research Forum: Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology [J].
March, J ;
Kratochvil, C ;
Clarke, G ;
Beardslee, W ;
Derivan, A ;
Emslie, G ;
Green, EP ;
Heiligenstein, J ;
Hinshaw, S ;
Hoagwood, K ;
Jensen, P ;
Lavori, P ;
Leonard, H ;
McNulty, J ;
Michaels, MA ;
Mossholder, A ;
Osher, T ;
Petti, T ;
Prentice, E ;
Vitiello, B ;
Wells, K .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2004, 43 (08) :1046-1056
[25]   Psychopharmacology and mental retardation: a 10 year review (1990-1999) [J].
Matson, JL ;
Bamburg, JW ;
Mayville, EA ;
Pinkston, J ;
Bielecki, J ;
Kuhn, D ;
Smalls, Y ;
Logan, JR .
RESEARCH IN DEVELOPMENTAL DISABILITIES, 2000, 21 (04) :263-296
[26]   Intent-to-treat analysis for longitudinal clinical trials: coping with the challenge of missing values [J].
Mazumdar, S ;
Liu, KS ;
Houck, PR ;
Reynolds, CF .
JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (02) :87-95
[27]  
McAdam DB, 2002, AM J MENT RETARD, V107, P261, DOI 10.1352/0895-8017(2002)107<0261:EOROAB>2.0.CO
[28]  
2
[29]  
MCCANNELL KL, 1995, TXB PHARM, P75
[30]  
Napolitano DA, 1999, MENT RETARD DEV D R, V5, P322, DOI 10.1002/(SICI)1098-2779(1999)5:4<322::AID-MRDD10>3.3.CO